Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid CarcinomaJennifer Wang, Maria E. Cabanillas, Michelle D. Williams et al.|Thyroid|2019Cited by 229
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF <sup>V600E</sup> -Mutated Anaplastic Thyroid CarcinomaSarah Hamidi, Maria E. Cabanillas, Priyanka Iyer et al.|Thyroid|2024Cited by 72
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E. Cabanillas, Sarah Hamidi, Renata Ferrarotto et al.|Thyroid|2025Cited by 8
Imaging characteristics of 4th ventricle subependymomaAli S. Haider, Maria Gule-Monroe, Kimmo J. Hatanpaa et al.|Neuroradiology|2022Cited by 4
Cobimetinib plus atezolizumab for <i>RAS</i> and <i>NF</i>1/2-mutated poorly differentiated thyroid carcinoma.Sarah Hamidi, Scott E. Woodman, Renata Ferrarotto et al.|Journal of Clinical Oncology|2024Cited by 4